Skip to main content
Anna Langlois on Muck Rack

Anna Langlois

Verified
(She/Her)
Washington, D.C.
As seen in: Global Competition Review, Lexology, Intellectual Asset Management
Covers:  antitrust, competition, criminal enforcement, mergers
antitrust reporter and chart doyen at @GCR_alerts views are my own tips welcome: signal @ annalanglois.70

Get in touch with Anna

Contact Anna, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Anna Langlois’s Biography

Read Full Bio →

Antitrust at GCR USA. Tips welcome - anna.langlois@lbresearch.com

Anna Langlois’s Journalist Portfolio

Bid-rigging reversal risks "serious blow" to DOJ, practitioners say

Bid-rigging reversal risks "serious blow" to DOJ, practitioners say

The Department of Justice has signalled it will appeal against an overturned bid-rigging conviction that seve…

View article →

Articles

States split over DOJ/Live Nation deal discovery

|
By Anna Langlois Verified, Mark Taylor, Gcr Usa
| Global Competition Review Verified
4 min read | | An alliance of state attorneys general is divided on whether to seek discovery in the Tunney Act proceedings for the Department of Justice’s settlement with Live Nation. Subscribe to Global Competition Review Register for free to unlock full access to our Insight content, including Guides, Reviews and Hubs. Plus, get our newsletter straight to your inbox. Register now Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Open in Who Shared View Duplicates (4) Issue with article?

FTC settles rebate, price concerns with CVS

|
By Anna Langlois Verified, Gcr Usa
| Global Competition Review Verified
3 min read | | Credit: Shutterstock.com/DCStockPhotography CVS Caremark has settled claims with the Federal Trade Commission that it manipulated prices and used anticompetitive and unfair rebating practices, resolving a long-running battle between the agency and the pharmacy benefit manager. Subscribe to Global Competition Review Register for free to unlock full access to our Insight content, including Guides, Reviews and Hubs. Plus, get our newsletter straight to your inbox.
Open in Who Shared Issue with article?

Edwards Lifesciences to pay record $10m for HSR evasion

|
By Anna Langlois Verified, Mark Taylor, Gcr Usa
| Global Competition Review Verified
3 min read | | Edwards Lifesciences and Singapore-based Genesis MedTech have settled claims brought by the Department of Justice that they deliberately structured their 2024 merger to avoid antitrust scrutiny. Subscribe to Global Competition Review Register for free to unlock full access to our Insight content, including Guides, Reviews and Hubs. Plus, get our newsletter straight to your inbox.
Open in Who Shared Issue with article?
See all 656 articles